Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 2/20 | 0.35 |
| ▸ | CCR8 | P51685 | 2/20 | 0.35 |
| ▸ | BDKRB2 | P30411 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175672 | 0.96 | CCR1 (0.38) | CCR1CCR5CCR8BDKRB2CYP2D6 | |
| SCHEMBL145233 | 0.90 | CCR1 (0.33) | CCR1CCR5CCR8BDKRB2CYP2D6 | |
| SCHEMBL3040111 | 0.90 | NR1I2 (0.39) | CCR1CCR5CCR8BDKRB2CYP2D6 | |
| SCHEMBL174988 | 0.90 | NR1I2 (0.39) | CCR1CCR5CCR8BDKRB2KDM5A | |
| Bromide SCHEMBL2521169 | 0.86 | POLB (0.35) | CYP2D6CYP19A1CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL2511650 | 0.86 | KDM5A (0.35) | ALDH1A1POLBKDM5AKDM5B | |
| SCHEMBL13039644 | 0.85 | LNPEP (0.37) | MAPT | |
| SCHEMBL5974098 | 0.83 | NR1I2 (0.47) | CCR1CCR5CCR8BDKRB2KDM5A | |
| SCHEMBL2136994 | 0.81 | ALDH1A1 (0.35) | CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL8527154 | 0.79 | NOS2 (0.46) | BDKRB2CYP2C9CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8034971-B2 | Method for producing 1,2-phenylethane compound using atom transfer radical coupling reaction | NIPPON SODA CO., LTD. (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20090275772-A1 | Metrod for Producing 1,2-Phenylethane Compound Using Atom Transfer Radical Coupling Reaction | NIPPON SODA CO., LTD. (JP) | 2009-11-05 | — | — | US | disclosed |
| US-7579401-B2 | Block polymer of polymethoxypolyethylene glycol monomethyl methacrylate and polystyrene; LiClO4 a lithium salt as electrolyte; living copolymerization, block polymerization; excellent thermal characteristics, physical characteristics, and ionic conductivity; secondary batteries | NIPPON SODA CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| EP-1997798-A1 | METHOD FOR PRODUCING 1,2-PHENYLETHANE COMPOUND USING ATOM TRANSFER RADICAL COUPLING REACTION | Nippon Soda Co., Ltd. (JP) | 2008-12-03 | — | — | EP | disclosed |
| EP-1553117-B1 | SOLID POLYMER ELECTROLYTE | NIPPON SODA CO (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20050256256-A1 | Block polymer of polymethoxypolyethylene glycol monomethyl methacrylate and polystyrene; LiClO4 a lithium salt as electrolyte; living copolymerization, block polymerization; excellent thermal characteristics, physical characteristics, and ionic conductivity; secondary batteries | NIPPON SODA CO., LTD (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1553117-A1 | SOLID POLYMER ELECTROLYTE | NIPPON SODA CO., LTD. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275772-A1 | Metrod for Producing 1,2-Phenylethane Compound Using Atom Transfer Radical Coupling Reaction | ROS1, MET, MT-CO1 | CCR1 1794/4885CCR5 2911/4885CCR8 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.